Gene Symbol | Gene ID | Gene Info |
---|---|---|
Crx
|
ENSMUSG00000041578.9 | cone-rod homeobox |
Gsc
|
ENSMUSG00000021095.4 | goosecoid homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_104472859_104473455 | Gsc | 173 | 0.487669 | 0.49 | 1.3e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_101978900_101979253 | 11.44 |
Gm13919 |
predicted gene 13919 |
60553 |
0.11 |
chr2_50971005_50971315 | 10.57 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr3_39047740_39047911 | 10.46 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr8_98309461_98309682 | 10.23 |
Gm7192 |
predicted gene 7192 |
84908 |
0.1 |
chr6_100025745_100025937 | 8.72 |
Gm33201 |
predicted gene, 33201 |
34626 |
0.17 |
chr4_86019686_86019889 | 8.54 |
Gm25811 |
predicted gene, 25811 |
23707 |
0.23 |
chr8_55026049_55026477 | 8.47 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr12_90132535_90132958 | 8.41 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr13_81628689_81629170 | 8.38 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
4210 |
0.23 |
chr13_84065521_84065798 | 8.06 |
Gm17750 |
predicted gene, 17750 |
887 |
0.64 |
chr11_71758404_71758886 | 8.03 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chrX_13346707_13347908 | 7.95 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr9_20682215_20682396 | 7.79 |
Olfm2 |
olfactomedin 2 |
9174 |
0.13 |
chr10_42578232_42578446 | 7.77 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
2006 |
0.32 |
chr15_91017743_91018222 | 7.75 |
Kif21a |
kinesin family member 21A |
31836 |
0.16 |
chr14_14350947_14351733 | 7.75 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr2_37931114_37931298 | 7.61 |
Dennd1a |
DENN/MADD domain containing 1A |
78766 |
0.08 |
chr8_90536467_90536639 | 7.60 |
Gm45639 |
predicted gene 45639 |
138405 |
0.04 |
chr15_25753970_25754154 | 7.53 |
Myo10 |
myosin X |
1083 |
0.59 |
chr12_117257705_117257898 | 7.48 |
Mir153 |
microRNA 153 |
6984 |
0.29 |
chr1_81593373_81593581 | 7.39 |
Gm6198 |
predicted gene 6198 |
35994 |
0.2 |
chrX_42361483_42361664 | 7.36 |
Gm14619 |
predicted gene 14619 |
14061 |
0.27 |
chr18_60065037_60065286 | 7.34 |
Gm23576 |
predicted gene, 23576 |
109156 |
0.06 |
chr6_141568214_141568517 | 7.33 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
22201 |
0.23 |
chr6_53624960_53625159 | 7.33 |
Gm44080 |
predicted gene, 44080 |
42711 |
0.16 |
chr1_41605098_41605443 | 7.25 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr8_108102586_108102755 | 7.24 |
Zfhx3 |
zinc finger homeobox 3 |
108111 |
0.07 |
chr1_132200708_132201234 | 7.09 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr2_51753056_51753280 | 7.06 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr6_28980766_28981191 | 7.00 |
Gm3294 |
predicted gene 3294 |
656 |
0.73 |
chr2_157487979_157488189 | 6.98 |
Src |
Rous sarcoma oncogene |
30999 |
0.11 |
chr10_22609004_22609241 | 6.81 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr15_83765468_83765992 | 6.79 |
Mpped1 |
metallophosphoesterase domain containing 1 |
13737 |
0.21 |
chr18_45896851_45897467 | 6.71 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr9_35400958_35401147 | 6.61 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
20076 |
0.14 |
chr2_41669936_41670198 | 6.55 |
Lrp1b |
low density lipoprotein-related protein 1B |
119011 |
0.07 |
chr15_27811126_27811398 | 6.54 |
Trio |
triple functional domain (PTPRF interacting) |
12521 |
0.21 |
chr5_71095688_71096242 | 6.51 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
116 |
0.98 |
chr13_29273638_29274140 | 6.49 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr7_92984793_92985009 | 6.44 |
Gm31663 |
predicted gene, 31663 |
2849 |
0.25 |
chr2_141074597_141074768 | 6.36 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
50620 |
0.15 |
chr1_88668381_88668740 | 6.30 |
Gm29336 |
predicted gene 29336 |
12252 |
0.16 |
chr18_16669615_16669766 | 6.30 |
Cdh2 |
cadherin 2 |
379 |
0.91 |
chr2_80129445_80129882 | 6.27 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
205 |
0.94 |
chr2_148264197_148264394 | 6.25 |
Gm24221 |
predicted gene, 24221 |
113145 |
0.05 |
chr1_109982419_109982761 | 6.24 |
Cdh7 |
cadherin 7, type 2 |
120 |
0.98 |
chr5_10417082_10417233 | 6.21 |
Gm17091 |
predicted gene 17091 |
120128 |
0.05 |
chr6_126768206_126768472 | 6.15 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
27665 |
0.13 |
chr9_40268412_40269319 | 6.13 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr3_68071449_68071752 | 6.10 |
Schip1 |
schwannomin interacting protein 1 |
6798 |
0.31 |
chr4_72384628_72385513 | 6.10 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr18_43510044_43510283 | 6.09 |
AC156546.1 |
novel transcript |
19717 |
0.14 |
chr14_61005137_61005288 | 6.08 |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
29327 |
0.18 |
chr3_94484401_94484863 | 6.07 |
Celf3 |
CUGBP, Elav-like family member 3 |
261 |
0.81 |
chr11_78786013_78786424 | 6.05 |
Gm23840 |
predicted gene, 23840 |
31696 |
0.11 |
chr7_79590405_79591230 | 6.04 |
Gm45169 |
predicted gene 45169 |
1796 |
0.2 |
chr2_147702775_147702949 | 6.03 |
A530006G24Rik |
RIKEN cDNA A530006G24 gene |
7831 |
0.23 |
chr14_21411188_21411393 | 6.03 |
Gm25864 |
predicted gene, 25864 |
39184 |
0.14 |
chr13_26656976_26657325 | 6.00 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr11_37153919_37154124 | 5.98 |
Tenm2 |
teneurin transmembrane protein 2 |
81861 |
0.12 |
chr5_109556763_109557843 | 5.96 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr12_49383638_49384096 | 5.94 |
Foxg1 |
forkhead box G1 |
860 |
0.39 |
chr11_114467854_114468223 | 5.92 |
4932435O22Rik |
RIKEN cDNA 4932435O22 gene |
19178 |
0.23 |
chr5_150905805_150906370 | 5.91 |
Gm43298 |
predicted gene 43298 |
23445 |
0.17 |
chr9_83664968_83665283 | 5.90 |
Gm36120 |
predicted gene, 36120 |
22400 |
0.17 |
chr10_29213823_29213974 | 5.90 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
2193 |
0.27 |
chr18_72554245_72554433 | 5.87 |
Gm6995 |
predicted gene 6995 |
127231 |
0.06 |
chr5_84848501_84849167 | 5.86 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr12_26635762_26635979 | 5.86 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33561 |
0.18 |
chr10_103726584_103727032 | 5.86 |
Gm47224 |
predicted gene, 47224 |
131524 |
0.04 |
chr14_64533719_64533870 | 5.85 |
Gm47202 |
predicted gene, 47202 |
3744 |
0.24 |
chr15_8815380_8815535 | 5.84 |
Gm5043 |
predicted gene 5043 |
99027 |
0.07 |
chr13_71558486_71558841 | 5.84 |
Gm47811 |
predicted gene, 47811 |
66311 |
0.11 |
chr19_28337285_28337436 | 5.80 |
Glis3 |
GLIS family zinc finger 3 |
11354 |
0.29 |
chr12_7029541_7029692 | 5.80 |
Gm46311 |
predicted gene, 46311 |
62656 |
0.16 |
chr7_93076588_93076767 | 5.79 |
Fam181b |
family with sequence similarity 181, member B |
3188 |
0.22 |
chr12_98059488_98059651 | 5.75 |
Gm35412 |
predicted gene, 35412 |
40786 |
0.16 |
chr18_25548275_25548710 | 5.75 |
Celf4 |
CUGBP, Elav-like family member 4 |
47253 |
0.16 |
chr2_33812630_33813034 | 5.74 |
Nron |
non-protein coding RNA, repressor of NFAT |
6973 |
0.22 |
chr6_136172482_136172648 | 5.66 |
Gm26653 |
predicted gene, 26653 |
496 |
0.51 |
chr13_9355426_9355612 | 5.62 |
Gm48869 |
predicted gene, 48869 |
3491 |
0.17 |
chr3_17793898_17794135 | 5.59 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
71 |
0.96 |
chr9_45657127_45657508 | 5.58 |
Dscaml1 |
DS cell adhesion molecule like 1 |
15520 |
0.18 |
chr5_89943596_89944012 | 5.56 |
Adamts3 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
60470 |
0.14 |
chr1_57862082_57862411 | 5.54 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
16675 |
0.22 |
chr6_144251546_144251744 | 5.52 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42077 |
0.21 |
chr15_85464224_85464612 | 5.52 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
38809 |
0.14 |
chr12_7029729_7029880 | 5.52 |
Gm46311 |
predicted gene, 46311 |
62844 |
0.16 |
chr11_35151538_35151723 | 5.50 |
Slit3 |
slit guidance ligand 3 |
19999 |
0.24 |
chr10_122602448_122602619 | 5.48 |
A130077B15Rik |
RIKEN cDNA A130077B15 gene |
32642 |
0.14 |
chr10_51257840_51258054 | 5.46 |
Gm5040 |
predicted gene 5040 |
19118 |
0.23 |
chr2_74426718_74427115 | 5.46 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr8_4492910_4494136 | 5.46 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr5_90988282_90988433 | 5.45 |
Epgn |
epithelial mitogen |
39107 |
0.11 |
chr1_131770683_131771116 | 5.43 |
Slc26a9 |
solute carrier family 26, member 9 |
20408 |
0.14 |
chr6_144313023_144313448 | 5.39 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chr2_151631930_151632148 | 5.37 |
Snph |
syntaphilin |
432 |
0.78 |
chr1_33494905_33495073 | 5.36 |
Gm29228 |
predicted gene 29228 |
12888 |
0.21 |
chr18_81509336_81509702 | 5.35 |
Gm50412 |
predicted gene, 50412 |
29162 |
0.19 |
chr1_126681823_126682058 | 5.32 |
Nckap5 |
NCK-associated protein 5 |
56250 |
0.17 |
chr2_57267510_57267661 | 5.32 |
Gpd2 |
glycerol phosphate dehydrogenase 2, mitochondrial |
208 |
0.93 |
chr4_65238564_65239062 | 5.31 |
Pappa |
pregnancy-associated plasma protein A |
114639 |
0.07 |
chr4_139758638_139758809 | 5.30 |
Pax7 |
paired box 7 |
74284 |
0.08 |
chr3_5225558_5225711 | 5.30 |
Zfhx4 |
zinc finger homeodomain 4 |
4129 |
0.22 |
chr8_57922585_57922771 | 5.28 |
Gm45633 |
predicted gene 45633 |
30935 |
0.19 |
chr17_70633998_70634208 | 5.27 |
Dlgap1 |
DLG associated protein 1 |
72551 |
0.1 |
chr2_105688527_105688678 | 5.27 |
Pax6 |
paired box 6 |
3280 |
0.21 |
chr18_44581816_44582060 | 5.25 |
Mcc |
mutated in colorectal cancers |
62422 |
0.12 |
chr13_78629094_78629308 | 5.23 |
Gm48402 |
predicted gene, 48402 |
8816 |
0.3 |
chr8_125226975_125227173 | 5.21 |
Gm16237 |
predicted gene 16237 |
249 |
0.95 |
chr2_106781887_106782038 | 5.21 |
Gm22813 |
predicted gene, 22813 |
27373 |
0.19 |
chr7_130215830_130216263 | 5.20 |
Fgfr2 |
fibroblast growth factor receptor 2 |
12710 |
0.28 |
chr18_23494681_23494880 | 5.19 |
Dtna |
dystrobrevin alpha |
2055 |
0.46 |
chr6_93912200_93912424 | 5.13 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
192 |
0.96 |
chr14_22358353_22358516 | 5.13 |
Lrmda |
leucine rich melanocyte differentiation associated |
48269 |
0.18 |
chr3_37569972_37570156 | 5.10 |
Spata5 |
spermatogenesis associated 5 |
3554 |
0.16 |
chr18_73369664_73369876 | 5.10 |
n-R5-8s1 |
nuclear encoded rRNA 5.8S 1 |
163780 |
0.04 |
chr9_77502495_77502690 | 5.10 |
Lrrc1 |
leucine rich repeat containing 1 |
29852 |
0.14 |
chr3_105529884_105530167 | 5.10 |
Gm43847 |
predicted gene 43847 |
27118 |
0.18 |
chr12_80759665_80760570 | 5.07 |
Ccdc177 |
coiled-coil domain containing 177 |
570 |
0.61 |
chr18_29363074_29363264 | 5.06 |
4930527G23Rik |
RIKEN cDNA 4930527G23 gene |
79031 |
0.11 |
chrX_161926333_161926696 | 5.03 |
Gm15202 |
predicted gene 15202 |
18291 |
0.25 |
chr9_37430671_37431052 | 5.03 |
Robo3 |
roundabout guidance receptor 3 |
727 |
0.55 |
chr12_99286735_99286977 | 5.03 |
Foxn3 |
forkhead box N3 |
4421 |
0.18 |
chr2_19910475_19910626 | 5.01 |
Etl4 |
enhancer trap locus 4 |
770 |
0.63 |
chr4_74013078_74013818 | 5.00 |
Frmd3 |
FERM domain containing 3 |
4 |
0.98 |
chr5_14834201_14834402 | 5.00 |
Gm43665 |
predicted gene 43665 |
29400 |
0.17 |
chr19_40434410_40434919 | 4.99 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
16723 |
0.21 |
chr8_45508006_45508255 | 4.98 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
212 |
0.94 |
chr16_62690482_62690670 | 4.94 |
Gm9816 |
predicted pseudogene 9816 |
26461 |
0.19 |
chr1_167119518_167119861 | 4.93 |
Gm17868 |
predicted gene, 17868 |
21466 |
0.19 |
chr13_107247476_107247653 | 4.91 |
Gm2726 |
predicted gene 2726 |
32627 |
0.2 |
chr2_146724257_146724438 | 4.90 |
Gm14111 |
predicted gene 14111 |
31358 |
0.22 |
chr3_88233361_88233562 | 4.90 |
Gm3764 |
predicted gene 3764 |
4678 |
0.09 |
chrX_99213901_99214052 | 4.90 |
Efnb1 |
ephrin B1 |
75845 |
0.11 |
chr10_91881593_91881813 | 4.86 |
Gm31592 |
predicted gene, 31592 |
7126 |
0.31 |
chr16_64068644_64068823 | 4.85 |
Gm49627 |
predicted gene, 49627 |
113603 |
0.07 |
chr3_121489477_121489703 | 4.83 |
Slc44a3 |
solute carrier family 44, member 3 |
28679 |
0.13 |
chr10_87420178_87420399 | 4.83 |
Gm23191 |
predicted gene, 23191 |
56142 |
0.12 |
chr16_45799306_45799457 | 4.83 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
2190 |
0.31 |
chr6_55388308_55389212 | 4.81 |
6430584L05Rik |
RIKEN cDNA 6430584L05 gene |
8127 |
0.17 |
chr12_5226980_5227176 | 4.80 |
Gm48532 |
predicted gene, 48532 |
8886 |
0.26 |
chr7_83549402_83549802 | 4.78 |
Gm10610 |
predicted gene 10610 |
654 |
0.69 |
chr7_124667697_124667848 | 4.77 |
3100003L05Rik |
RIKEN cDNA 3100003L05 gene |
41163 |
0.21 |
chr9_35360767_35361018 | 4.77 |
2610105M22Rik |
RIKEN cDNA 2610105M22 gene |
2221 |
0.26 |
chr6_22794880_22795138 | 4.75 |
Gm25942 |
predicted gene, 25942 |
5191 |
0.17 |
chr4_32923442_32923826 | 4.74 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr10_25571366_25571532 | 4.74 |
Gm29571 |
predicted gene 29571 |
35063 |
0.13 |
chr19_26340291_26340442 | 4.74 |
Gm50377 |
predicted gene, 50377 |
31659 |
0.19 |
chr11_19093526_19093677 | 4.72 |
Gm37439 |
predicted gene, 37439 |
23833 |
0.16 |
chr18_43509676_43509832 | 4.70 |
AC156546.1 |
novel transcript |
20126 |
0.14 |
chr18_9216377_9216790 | 4.70 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr16_94931404_94931589 | 4.70 |
Gm22745 |
predicted gene, 22745 |
62032 |
0.12 |
chr10_49256416_49256586 | 4.70 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
13465 |
0.18 |
chr17_88670045_88670274 | 4.69 |
Gtf2a1l |
general transcription factor IIA, 1-like |
1463 |
0.38 |
chr13_57450414_57450568 | 4.68 |
Gm48176 |
predicted gene, 48176 |
173813 |
0.03 |
chr10_58227289_58228680 | 4.67 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr4_122998402_122999232 | 4.67 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr1_177322736_177322969 | 4.66 |
Gm38328 |
predicted gene, 38328 |
53500 |
0.11 |
chr1_9127833_9128130 | 4.66 |
Gm37629 |
predicted gene, 37629 |
64135 |
0.12 |
chr12_100338158_100338355 | 4.66 |
Ttc7b |
tetratricopeptide repeat domain 7B |
40 |
0.98 |
chr11_35527923_35528248 | 4.65 |
Slit3 |
slit guidance ligand 3 |
16600 |
0.26 |
chr7_136083569_136083918 | 4.65 |
Gm36737 |
predicted gene, 36737 |
89553 |
0.08 |
chrX_152656185_152656553 | 4.63 |
Shroom2 |
shroom family member 2 |
11826 |
0.22 |
chr12_108689235_108689960 | 4.63 |
Degs2 |
delta(4)-desaturase, sphingolipid 2 |
2586 |
0.17 |
chr16_77885099_77885368 | 4.62 |
Gm17333 |
predicted gene, 17333 |
38629 |
0.18 |
chr18_25554284_25554443 | 4.62 |
Gm3227 |
predicted gene 3227 |
43127 |
0.17 |
chr14_79936974_79937129 | 4.59 |
Gm18605 |
predicted gene, 18605 |
10606 |
0.17 |
chr8_25392912_25393353 | 4.55 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr13_115427753_115427904 | 4.55 |
Gm6035 |
predicted gene 6035 |
101944 |
0.08 |
chr11_63246366_63246517 | 4.52 |
Gm12285 |
predicted gene 12285 |
4966 |
0.26 |
chr19_7083550_7083737 | 4.51 |
AC109619.1 |
novel transcript, antisense to Macrod1 |
4778 |
0.13 |
chr13_25750886_25751367 | 4.51 |
Gm11350 |
predicted gene 11350 |
69983 |
0.13 |
chr4_126602487_126602688 | 4.51 |
5730409E04Rik |
RIKEN cDNA 5730409E04Rik gene |
7231 |
0.13 |
chr11_41160650_41160838 | 4.50 |
Hmgb1-ps1 |
high mobility group box 1, pseudogene 1 |
18981 |
0.24 |
chr10_60952677_60952828 | 4.49 |
Mir466j |
microRNA 466j |
7971 |
0.14 |
chr6_112809545_112809826 | 4.49 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr8_69122168_69122328 | 4.49 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
18705 |
0.14 |
chr9_27174095_27174444 | 4.47 |
Jam3 |
junction adhesion molecule 3 |
18848 |
0.17 |
chr3_127387010_127387518 | 4.47 |
Gm42969 |
predicted gene 42969 |
6442 |
0.16 |
chr16_45999549_45999806 | 4.44 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
10541 |
0.16 |
chr10_101302250_101302439 | 4.43 |
Gm19233 |
predicted gene, 19233 |
30723 |
0.25 |
chr14_35113129_35113312 | 4.43 |
Gm49034 |
predicted gene, 49034 |
106218 |
0.07 |
chr8_65068232_65068455 | 4.42 |
Gm10663 |
predicted gene 10663 |
6690 |
0.1 |
chr1_70442796_70442968 | 4.41 |
Gm38272 |
predicted gene, 38272 |
129971 |
0.05 |
chr7_73354299_73354479 | 4.41 |
Rgma |
repulsive guidance molecule family member A |
21120 |
0.13 |
chr17_29736500_29736690 | 4.40 |
1810014P07Rik |
RIKEN cDNA 1810014P07 gene |
19523 |
0.13 |
chr10_10847498_10847649 | 4.39 |
4930567K20Rik |
RIKEN cDNA 4930567K20 gene |
96493 |
0.07 |
chr14_19977078_19977720 | 4.39 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr4_72167731_72168270 | 4.38 |
Gm11250 |
predicted gene 11250 |
768 |
0.7 |
chr16_74397266_74397471 | 4.37 |
Robo2 |
roundabout guidance receptor 2 |
13544 |
0.25 |
chr1_69105558_69105758 | 4.37 |
Gm16076 |
predicted gene 16076 |
1082 |
0.49 |
chr9_69592495_69592684 | 4.36 |
Gm47203 |
predicted gene, 47203 |
7165 |
0.25 |
chr18_23516482_23516843 | 4.35 |
Dtna |
dystrobrevin alpha |
16097 |
0.28 |
chr7_83037263_83037414 | 4.35 |
A530021J07Rik |
Riken cDNA A530021J07 gene |
24445 |
0.17 |
chr10_29213650_29213801 | 4.35 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
2020 |
0.29 |
chr14_66344453_66344629 | 4.32 |
Stmn4 |
stathmin-like 4 |
160 |
0.95 |
chr1_173389363_173389746 | 4.32 |
Cadm3 |
cell adhesion molecule 3 |
21859 |
0.15 |
chr11_77851092_77851280 | 4.30 |
Myo18a |
myosin XVIIIA |
530 |
0.74 |
chr8_93917847_93918490 | 4.27 |
Gm24159 |
predicted gene, 24159 |
15768 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.9 | 9.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.7 | 3.3 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.7 | 6.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.4 | 7.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.4 | 17.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.3 | 2.6 | GO:0048880 | sensory system development(GO:0048880) |
1.3 | 3.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.3 | 3.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.3 | 3.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.2 | 3.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.2 | 2.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 3.4 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.1 | 5.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.1 | 6.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.0 | 6.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 1.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.9 | 7.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 8.5 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.9 | 1.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.9 | 2.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 2.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 2.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 3.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 2.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 3.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 3.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 3.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 2.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 1.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 1.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.7 | 2.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 5.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 2.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.7 | 1.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.7 | 2.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.1 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.7 | 2.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.7 | 2.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 2.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 7.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.6 | 3.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.6 | 2.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 1.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.6 | 1.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 2.4 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 1.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 4.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 0.6 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 4.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 4.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.5 | 2.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 0.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 1.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 3.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 0.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.5 | 4.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 1.0 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.5 | 2.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 1.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 1.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 2.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 1.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 5.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 1.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 1.4 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.5 | 0.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.5 | 0.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 1.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 0.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 4.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.5 | 1.4 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.5 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 2.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 2.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 1.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 1.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 3.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 1.7 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.4 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.4 | 2.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 1.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 1.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 1.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 1.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 2.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 0.8 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 0.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.4 | 7.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 1.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 1.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.4 | 31.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 6.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.4 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 2.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 1.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 1.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 1.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 0.3 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 5.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 1.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 0.3 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.3 | 6.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 2.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 1.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.3 | 1.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 1.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 4.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 3.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 1.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 1.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 2.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 1.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 0.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 1.6 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 2.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.3 | 0.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 3.7 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 1.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 1.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 1.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 1.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.2 | 1.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 1.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 4.2 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 1.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 1.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 2.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:0072050 | paramesonephric duct development(GO:0061205) S-shaped body morphogenesis(GO:0072050) |
0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 2.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 1.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.4 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 3.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 1.6 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.8 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 2.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 1.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 0.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0098868 | bone growth(GO:0098868) |
0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.7 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.2 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 1.6 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 0.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 3.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.2 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 2.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 2.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 5.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.2 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.2 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 4.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.2 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 1.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 4.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.2 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.3 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 2.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 1.4 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 1.8 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.4 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 2.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 1.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 1.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 1.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) oviduct development(GO:0060066) |
0.1 | 0.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 1.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 3.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 1.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.9 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.4 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 2.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.1 | 0.3 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.1 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 1.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 2.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.5 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.1 | 1.7 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.3 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.6 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 1.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 3.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 1.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.3 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 2.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 0.9 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 1.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 4.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.4 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.4 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 1.0 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0002885 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) positive regulation of hypersensitivity(GO:0002885) type I hypersensitivity(GO:0016068) |
0.0 | 0.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 1.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.5 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.0 | 0.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.0 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.0 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.0 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.0 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.0 | 0.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.4 | 5.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.2 | 8.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 3.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 3.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 8.3 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 2.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 6.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 3.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 7.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 2.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 4.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 1.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 4.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 6.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.5 | 5.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 2.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 1.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 0.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 7.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 3.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 3.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 5.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 2.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 2.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 6.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 11.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 5.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 5.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 10.6 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.3 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 19.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 2.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 5.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 2.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 5.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 6.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0036379 | myofilament(GO:0036379) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.3 | 7.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.8 | 5.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.6 | 4.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.5 | 4.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.5 | 4.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 5.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.3 | 2.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 3.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.1 | 3.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.0 | 5.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.9 | 3.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 4.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.8 | 2.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.8 | 3.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 5.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 3.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 10.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 2.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 6.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 4.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 4.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 2.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 1.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 1.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 2.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.4 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 8.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 10.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 2.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 1.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 4.2 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 5.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 7.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 5.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.9 | GO:0016917 | G-protein coupled GABA receptor activity(GO:0004965) GABA receptor activity(GO:0016917) |
0.3 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 4.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 1.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 2.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 5.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 2.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 3.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 12.1 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 3.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 5.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 5.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 3.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 2.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 3.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 4.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 1.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 7.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 1.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.9 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 3.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 3.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.8 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 2.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 2.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.3 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 5.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 3.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 2.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 9.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 1.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.3 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.0 | GO:0018599 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 20.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 1.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 5.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 8.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 7.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 5.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 12.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 21.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 9.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 22.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 7.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 9.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 5.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 3.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 3.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 6.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 3.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 1.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 4.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 5.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 1.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 6.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 4.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |